Newsletter | 01 February 2003 Access News 8, Focus on Access Three Years On, February 2003 HIV/AIDS RESEARCH AND DEVELOPMENT TROPICAL & NEGLECTED DISEASES VACCINES The Access Campaign three years on is addressed in this issue of AccessNews, as well as the fear of another meningitis epidemic, Roche's failing of HIV patients, fighting against neglected diseases, no agreements at Doha and HIV positive children. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefTopic overviewVideo Research article | 14 August 2024 HIV/AIDS Lancet Global Health: Paving the way for affordable and equitable liposomal amphotericin B access worldwide Newsletter Newsletter | 02 August 2024 HIV/AIDS Why we went to the International AIDS Conference this year...and what we did! Photograph by Jan-Joseph Stok Press release Press release | 26 July 2024 HIV/AIDS Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs 5 min Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min Technical brief | 05 June 2024 HIV/AIDS Antiretroviral Prices in 2023 Photo credit: Lana Abramova Letter Letter | 29 April 2024 Diagnostics HIV/AIDS Tuberculosis Letters to Danaher and Cepheid 1 min Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test Load More
Research article | 14 August 2024 HIV/AIDS Lancet Global Health: Paving the way for affordable and equitable liposomal amphotericin B access worldwide
Newsletter Newsletter | 02 August 2024 HIV/AIDS Why we went to the International AIDS Conference this year...and what we did!
Photograph by Jan-Joseph Stok Press release Press release | 26 July 2024 HIV/AIDS Pharmaceutical corporation ViiV must urgently supply HIV drug CAB-LA according to global public health needs 5 min
Photo credit: MSF Press release Press release | 23 July 2024 HIV/AIDS Activists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot 3 min
Photo credit: Lana Abramova Letter Letter | 29 April 2024 Diagnostics HIV/AIDS Tuberculosis Letters to Danaher and Cepheid 1 min
Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min
Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test